CHRONIC HEMODYNAMIC-EFFECTS OF CARVEDILOL IN ESSENTIAL-HYPERTENSION AT REST AND DURING EXERCISE

被引:11
|
作者
LUNDJOHANSEN, P
OMVIK, P
机构
[1] Section of Cardiology, Medical Department, University of Bergen, School of Medicine, Haukeland Hospital
关键词
HYPERTENSION; HEMODYNAMICS; CARDIAC OUTPUT; EXERCISE; BETA-BLOCKERS; CARVEDILOL;
D O I
10.1093/oxfordjournals.eurheartj.a060160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen men (mean age 44 years) with essential hypertension, WHO stage I, were studied invasively at rest and during exercise. Blood pressure was recorded in intra-arterially (brachial artery), cardiac output by dye dilution method and heart rate by electrocardiography. After initial pre-drug recordings, the patients received 25 mg carvedilol orally and central haemodynamics at rest and during exercise were recorded 1 and 2 h after tablet in take to evaluate the immediate effects of curvedilol. The results indicated a combined β-blocking and vasodilating effect. After 6-9 months of treatment, supine haemodynamics were recorded 12-24 h after the last dose and then 1 and 2 h after an additional 25 mg dose. During chronic treatment (2 h after last dose at rest supine) mean arterial pressure was reduced by 17% (P <0.001) and total peripheral resistance index by 6% (NS) while heart rate and cardiac index were reduced by 12%. Exercise haemodynamics demonstratedafall in bloodpressure of 17% (P <0.001). Exercise stroke index increased by 5% (NS), partly compensatingfor the reduction in heart rate of 17%. Total peripheral resistance index was reduced by 5% (NS). It is concluded that carvedilol is an effective anti-hypertensive agent in a large proportion of patients with essential hypertension. The haemodynamic mode of action reflects an a1-blocking activity, particularly in situations with low sympathetic tone. During exercise the β1-blocking activity (demonstrated by the reduction in heart rate) is more prominent. © 1992 The European Society of Cardiology.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [31] VASCULAR HEMODYNAMIC-EFFECTS OF PERINDOPRIL IN ESSENTIAL-HYPERTENSION
    LITTLER, W
    DRUGS, 1990, 39 : 43 - 48
  • [32] HEMODYNAMIC-EFFECTS OF GUANFACINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    COHEN, AA
    FELDSTEIN, CA
    SABARIS, RP
    BURUCUA, JE
    MEDICINA-BUENOS AIRES, 1982, 42 (06) : 919 - 920
  • [33] HEMODYNAMIC-EFFECTS OF KETANSERIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    WOITTIEZ, AJJ
    WENTING, GJ
    MANINTVELD, AJ
    BOOMSMA, F
    SCHALEKAMP, MADH
    NETHERLANDS JOURNAL OF MEDICINE, 1983, 26 (02): : 60 - 61
  • [34] CLINICAL AND HEMODYNAMIC-EFFECTS OF CELIPROLOL IN ESSENTIAL-HYPERTENSION
    PARATI, G
    RAVOGLI, A
    BRAGATO, R
    OMBONI, S
    MUTTI, E
    MANCIA, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S14 - S21
  • [35] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN IN ESSENTIAL-HYPERTENSION
    RAM, CVS
    GONZALEZ, DG
    KAPLAN, NM
    RALAKIS, J
    HENDERSON, J
    CLINICAL RESEARCH, 1987, 35 (03): : A448 - A448
  • [36] ANTIHYPERTENSIVE AND HEMODYNAMIC-EFFECTS OF CAPTOPRIL IN ESSENTIAL-HYPERTENSION
    VALVO, E
    PREVIATO, G
    LUPO, A
    LOSCHIAVO, C
    TESSITORE, N
    OLDRIZZI, L
    GAMMARO, L
    MASCHIO, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (03): : 371 - 379
  • [37] COMPARISON OF LONG-TERM HEMODYNAMIC-EFFECTS AT REST AND DURING EXERCISE OF LISINOPRIL PLUS SODIUM RESTRICTION VERSUS HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION
    OMVIK, P
    LUNDJOHANSEN, P
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (05): : 331 - 338
  • [38] IMMEDIATE HEMODYNAMIC-EFFECTS OF URAPIDIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    KOBRIN, I
    AMODEO, C
    VENTURA, HO
    MESSERLI, FH
    FROHLICH, ED
    AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06): : 722 - 725
  • [39] ACUTE HEMODYNAMIC-EFFECTS OF INTRAVENOUS NICARDIPINE IN ESSENTIAL-HYPERTENSION
    MAUREL, C
    CHAIGNON, M
    GUEDON, J
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1987, 9 (11) : 1917 - 1917
  • [40] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN THERAPY IN ESSENTIAL-HYPERTENSION
    GONZALEZ, D
    RAM, CVS
    LUGO, C
    KAPLAN, N
    RALAKIS, J
    HENDERSON, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 221 - 221